PHGDH phosphorylation mediated by WNK1 serves as a dual marker of metabolic vulnerability and responsiveness to oxaliplatin treatment

Journal:
Proceedings of the National Academy of Sciences of the United States of America
Published:
DOI:
10.1073/pnas.2525213123
Affiliations:
9
Authors:
16
Go to article
Institutions Authors Share
China-US (Henan) Hormel Cancer Institute (CUHCI), China
6.200000
 0.39
Zhengzhou University (ZZU), China
4.700000
 0.29
Fuwai Central-China Hospital, China
1.400000
 0.09
Henan Cancer Hospital, ZZU, China
1.333333
 0.08
Henan Provincial People's Hospital, China
1.000000
 0.06
Tianjian Laboratory of Advanced Biomedical Sciences, China
0.866667
 0.05
Henan Academy of Sciences, China
0.500000
 0.03
Interested in Medical Biochemistry and Metabolomics?